Physicians should screen for colorectal cancer in asymptomatic, low-risk adults aged 50 to 74 years every two years using fecal occult blood testing (FOBT), or flexible sigmoidoscopy every 10 years, ...

Expensive colonoscopies that cost a patient over $1,000 on average could soon be replaced by simpler and much cheaper tests as non-invasive screening options become more available and more ...

People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests. Researchers focused on two widely used screenings. One, a ...

A recent study found that patients who had a positive fecal occult blood test (FOBT) but didn’t follow through with a colonoscopy had a fourfold higher risk for colorectal cancer (CRC) than the ...

A survey of adults eligible for colorectal cancer screening patterns found a preference for at-home fecal occult blood testing (FOBT) versus colonoscopy during the COVID-19 pandemic. Survey ...

Overall, 44.4% (55 of 124) of the programs assessed used colonoscopy as the primary screening test; 31.5% (n = 39) used FOBT/FIT, and 24.2% (n = 30) used both tests (Table 1). Of the programs that ...

For patients with a positive fecal occult blood test in a cohort study, those who did not undergo a follow-up colonoscopy had an increased incidence of colorectal cancer. Those who underwent ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Headlines are meant to grab your attention. So, if you read ...

When given a choice, most individuals with an average risk of colorectal cancer said they would prefer a stool-based screening test for colorectal cancer over colonoscopy, the method most often ...

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...